Lisa Licitra is specialised in Medical Oncology, with expertise in Head and Neck cancer treatment. She is Chief of Head and Neck Cancer Medical Oncology Dept, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. The Department has a unique focus on medical treatment of head and neck cancer patients with special expertise in HPV related tumour, testified by the high impacted published papers in this field.
Since 2009, she has been Associated Professor at Università degli Studi di Milano, chairing courses of Oncology in the Medical School and in Master of Biotechnology, Psycho-oncology, Pharmacology, International Medical School, Ear Nose Throat Specialty.
Since 2019, Prof Licitra is the Scientific Director of the Italian National Center for Oncological Hadrontherapy.
Board Member of EORTC - European Organization for the Research and Treatment of Cancer (2009- 2015) and 2018-2021 Vice President. Chair of Head and Neck Cancer Cooperative Group of EORTC for 3 years, at present Past Chair and Secretary of the EORTC Thyroid Task Force. Co-founder and member of the European Head and Neck Cancer Society. She acted as member of The Educational Committee of ESMO (European Society for Medical Oncology), the Clinical Editorial Board of Oral Oncology and the UICC TNM Staging Committee. Honorary Member of ESTRO European Society of Radiation Oncology. She is chair of G7 Domain in EURACAN.
Recipient of the Venosta AIRC/FIRC award. She won the ESMO Award in 2021.
Prof Licitra is author of 384 papers on peer-reviewed journals and her H-index is 64 (Scopus).
Dr Licitra has written 20 book chapters and approximately 152 scientific articles.